X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (928) 928
Book Review (141) 141
Publication (94) 94
Book Chapter (11) 11
Dissertation (2) 2
Conference Proceeding (1) 1
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (710) 710
humans (639) 639
fgfr3 (584) 584
mutation (328) 328
female (288) 288
male (280) 280
receptor, fibroblast growth factor, type 3 - genetics (276) 276
growth-factor receptor-3 (226) 226
oncology (215) 215
achondroplasia (210) 210
bladder cancer (184) 184
genetics & heredity (179) 179
cancer (166) 166
animals (161) 161
mutations (149) 149
fgfr3 mutations (148) 148
urinary bladder neoplasms - genetics (145) 145
genetic aspects (141) 141
tumors (138) 138
expression (135) 135
thanatophoric dysplasia (131) 131
adult (129) 129
receptors, fibroblast growth factor - genetics (128) 128
mice (127) 127
urinary bladder neoplasms - pathology (124) 124
receptor, fibroblast growth factor, type 3 (123) 123
aged (115) 115
middle aged (114) 114
fibroblast growth factors (109) 109
gene (107) 107
cell biology (97) 97
hypochondroplasia (96) 96
phenotype (93) 93
protein-tyrosine kinases (92) 92
prognosis (91) 91
achondroplasia - genetics (89) 89
receptor, fibroblast growth factor, type 3 - metabolism (88) 88
fibroblast growth factor receptor 3 (86) 86
pathology (86) 86
biochemistry & molecular biology (85) 85
analysis (82) 82
dna mutational analysis (82) 82
signal transduction (79) 79
activating mutations (77) 77
fibroblast growth factor receptors (76) 76
research (74) 74
dwarfism (72) 72
gene expression (72) 72
urology & nephrology (72) 72
genes (69) 69
child (66) 66
cell line, tumor (65) 65
urothelial carcinoma (65) 65
bladder (62) 62
child, preschool (61) 61
activation (60) 60
diagnosis (58) 58
infant (58) 58
polymerase chain reaction (57) 57
musculoskeletal diseases (56) 56
urinary-bladder (56) 56
adolescent (55) 55
aged, 80 and over (55) 55
fgfr3 gene (55) 55
fgfr3 mutation (55) 55
acanthosis nigricans (54) 54
point mutation (54) 54
skeletal dysplasia (54) 54
article (53) 53
carcinoma (53) 53
craniosynostosis (53) 53
dysplasia (53) 53
multiple-myeloma (52) 52
thanatophoric dysplasia - genetics (52) 52
growth (51) 51
immunohistochemistry (51) 51
transitional-cell carcinoma (50) 50
gene mutations (49) 49
infant, newborn (49) 49
pediatrics (49) 49
health aspects (48) 48
pregnancy (48) 48
apoptosis (47) 47
urinary bladder neoplasms - metabolism (47) 47
care and treatment (46) 46
gene expression regulation, neoplastic (46) 46
craniosynostoses - genetics (45) 45
urothelial cell-carcinoma (45) 45
urology (44) 44
fibroblast growth factor (43) 43
medicine & public health (43) 43
proteins (43) 43
bladder-cancer (42) 42
cell proliferation (41) 41
fibroblast-growth-factor (41) 41
mutation - genetics (41) 41
neoplasm staging (41) 41
development and progression (40) 40
kinases (40) 40
phosphorylation (40) 40
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Genetics, ISSN 1061-4036, 09/2011, Volume 43, Issue 9, pp. 875 - 878
Journal Article
Oncogene, ISSN 0950-9232, 12/2009, Volume 28, Issue 48, pp. 4306 - 4316
Although activating mutations of fibroblast growth factor receptor 3 (FGFR3) are frequent in bladder tumors, little information is available on their specific... 
Bladder | Fibroblast growth factor | Signaling | FGFR3 | Urothelium | DYSPLASIA TYPE-II | MULTIPLE-MYELOMA | BLADDER-CANCER | GAMMA-INDEPENDENT PATHWAYS | signaling | DIFFERENTIAL EXPRESSION | TUMOR PROGRESSION | BIOCHEMISTRY & MOLECULAR BIOLOGY | DOWN-REGULATION | urothelium | CELL BIOLOGY | fibroblast growth factor | THANATOPHORIC DYSPLASIA | ONCOLOGY | bladder | GENETICS & HEREDITY | ENDOPLASMIC-RETICULUM | FGFR3 MUTATIONS | Receptor, Fibroblast Growth Factor, Type 3 - genetics | MAP Kinase Signaling System - physiology | Phosphorylation | Humans | RNA, Small Interfering - pharmacology | Male | RNA, Small Interfering - physiology | Signal Transduction - genetics | Urothelium - pathology | Receptor, Fibroblast Growth Factor, Type 3 - physiology | Animals | MAP Kinase Signaling System - genetics | Transfection | Urinary Bladder Neoplasms - physiopathology | Signal Transduction - drug effects | Cell Transformation, Neoplastic - genetics | Urinary Bladder Neoplasms - congenital | Urinary Bladder Neoplasms - pathology | Cell Line, Tumor | Signal Transduction - physiology | Cell Proliferation - drug effects | Mice | Mutation | Amino Acid Substitution | Gene mutations | Physiological aspects | Cellular signal transduction | Genetic aspects | Research | Growth factor receptors | Health aspects | Oncology | Genetics | Cellular biology | Index Medicus
Journal Article
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, ISSN 0027-8424, 08/2007, Volume 104, Issue 33, pp. 13450 - 13454
Activating mutations of the p110 alpha subunit of PI3K (PIK3CA) oncogene have been identified in a broad spectrum of malignant tumors. However, their role in... 
BLADDER-CANCER | MULTIDISCIPLINARY SCIENCES | BENIGN SKIN TUMORS | oncogene | INDUCED SENESCENCE | PHOSPHOINOSITIDE 3-KINASE | senescence | CANCER-SPECIFIC MUTATIONS | GROWTH-FACTOR RECEPTOR-3 | HIGH-FREQUENCY | UROTHELIAL CELL-CARCINOMA | FGFR3 MUTATIONS | skin benign tumor | ACTIVATING MUTATIONS
Journal Article
Science Translational Medicine, ISSN 1946-6234, 08/2015, Volume 7, Issue 302, pp. 302ra133 - 302ra133
Journal Article
Journal Article
Oncogene, ISSN 0950-9232, 06/2001, Volume 20, Issue 27, pp. 3553 - 3562
Journal Article
European Urology, ISSN 0302-2838, 2016, Volume 71, Issue 6, pp. 961 - 969
Abstract Background Disease surveillance in patients with bladder cancer is important for early diagnosis of progression and metastasis and for optimised... 
Urology | Biomarker | PIK3CA | Cell-free DNA | Personalised analysis | Liquid biopsy | FGFR3 | Droplet digital polymerase chain reaction | UROTHELIAL CARCINOMA | CLONAL EVOLUTION | CIRCULATING TUMOR DNA | RADICAL CYSTECTOMY | URINE | UROLOGY & NEPHROLOGY | Class I Phosphatidylinositol 3-Kinases - urine | Predictive Value of Tests | Liquid Biopsy | Class I Phosphatidylinositol 3-Kinases - genetics | Circulating Tumor DNA - genetics | Urinary Bladder Neoplasms - blood | Humans | Middle Aged | Male | Receptor, Fibroblast Growth Factor, Type 3 - urine | Neoplasm Metastasis | Urinary Bladder Neoplasms - genetics | Time Factors | Biomarkers, Tumor - urine | DNA Mutational Analysis | Polymerase Chain Reaction | Class I Phosphatidylinositol 3-Kinases - blood | Female | Retrospective Studies | Receptor, Fibroblast Growth Factor, Type 3 - genetics | Urinary Bladder Neoplasms - urine | Genetic Predisposition to Disease | Neoplasm Invasiveness | Receptor, Fibroblast Growth Factor, Type 3 - blood | Risk Factors | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Proportional Hazards Models | Treatment Outcome | Urinary Bladder Neoplasms - surgery | Disease Progression | Biomarkers, Tumor - blood | Disease-Free Survival | Cystectomy | Phenotype | Circulating Tumor DNA - urine | Aged | Biomarkers, Tumor - genetics | Circulating Tumor DNA - blood | Mutation | Genetic aspects | Metastasis | Bladder cancer | Analysis | Genetic research | Development and progression | Index Medicus
Journal Article
International Journal of Cancer, ISSN 0020-7136, 10/2015, Volume 137, Issue 7, pp. 1621 - 1629
Journal Article
Annals of Oncology, ISSN 0923-7534, 07/2016, Volume 27, Issue 7, pp. 1311 - 1316
Journal Article
European Urology, ISSN 0302-2838, 2013, Volume 65, Issue 2, pp. 360 - 366
Journal Article